Published in PLoS One on February 10, 2014
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
AMPK in Health and Disease. Physiol Rev (2009) 6.38
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A (2000) 5.47
Adipose tissue as an endocrine organ. Mol Cell Endocrinol (2009) 5.20
Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology (2003) 5.09
Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab (1995) 3.34
Gender differences in insulin resistance, body composition, and energy balance. Gend Med (2009) 3.19
Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A (1998) 3.06
Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest (2003) 2.87
Adipose tissue as a buffer for daily lipid flux. Diabetologia (2002) 2.65
Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med (1997) 2.52
Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab (2003) 2.35
Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. J Biol Chem (2005) 2.24
Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia (2006) 1.90
Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab (2009) 1.69
Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci U S A (1999) 1.64
Epidemiology of nonalcoholic fatty liver. Clin Liver Dis (2004) 1.59
Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem Soc Trans (2005) 1.47
Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab (2004) 1.43
Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol (2006) 1.36
Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest (2000) 1.35
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet (2008) 1.35
Estrogen-related receptor alpha is a repressor of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem (2005) 1.31
Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol (2001) 1.28
Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab (2006) 1.27
Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Diabetes Metab Res Rev (2008) 1.24
Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med (2013) 1.22
Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis (2010) 1.22
Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology (2003) 1.18
Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol (2003) 1.17
Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab (2009) 1.07
Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy. Life Sci (2010) 0.98
Review article: hepatic steatosis and insulin resistance. Aliment Pharmacol Ther (2005) 0.96
Review article: the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2005) 0.92
A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse. J Endocrinol (2011) 0.91
Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. J Biol Chem (2008) 0.90
Hyperglycaemia, stress oxidant, liver dysfunction and histological changes in diabetic male rat pancreas and liver: protective effect of 17 beta-estradiol. Steroids (2008) 0.88
Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab (2009) 0.86
Pharmacologic management of nonalcoholic fatty liver disease. Clin Liver Dis (2004) 0.85
Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency. Horm Metab Res (2005) 0.83
Sex steroids deficiency impairs glucose transporter 4 expression and its translocation through defective Akt phosphorylation in target tissues of adult male rat. Metabolism (2009) 0.82
The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase. Horm Metab Res (2001) 0.81
Analysis of lipolysis in adipocytes using a fluorescent fatty acid derivative. Biochimie (2003) 0.78